Network Meta-Analysis Compares DOACs to LMWH for Cancer-Linked Thrombosis
Apixaban dominated enoxaparin and edoxaban; rivaroxaban was slightly more effective than apixaban
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.